Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study.

Diabetologia - 1 May 2020

Jujić Amra, Atabaki-Pasdar Naeimeh, Nilsson Peter M, Almgren Peter, Hakaste Liisa, Tuomi Tiinamaija, Berglund Lisa M, Franks Paul W, Holst Jens J, Prasad Rashmi B, Torekov Signe S, Ravassa Susana, Díez Javier, Persson Margaretha, Melander Olle, Gomez Maria F, Groop Leif, Ahlqvist Emma, Magnusson Martin

Abstract excerpt

AIMS/HYPOTHESIS: Evidence that glucose-dependent insulinotropic peptide (GIP) and/or the GIP receptor (GIPR) are involved in cardiovascular biology is emerging. We hypothesised that GIP has untoward effects on cardiovascular biology, in contrast to glucagon-like peptide 1 (GLP-1), and therefore investigated the effects of GIP and GLP-1 concentrations on cardiovascular disease (CVD) and mortality risk. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Glucagon-Like Peptide 1

Share to Glucose

Source

Open in PubMed Open full text

Identifiers

PMID: 31974732
DOI: 10.1007/s00125-020-05093-9
PMCID: PMC7145777

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study.PMID 31974732Read ↗

The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive ReviewSemantic proximity Read ↗

Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome.Semantic proximity Read ↗

Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk.Semantic proximity Read ↗

Risk of cardiovascular events associated with pathophysiological phenotypes of type 2 diabetes.Semantic proximity Read ↗

Exploring the pathways linking fasting insulin to coronary artery disease: a proteome-wide Mendelian randomization studySemantic proximity Read ↗

Investigating the role of inflammatory biomarkers and incretins in the aetiology of type 2 diabetes and coronary heart disease using human geneticsSemantic proximity Read ↗

Effect of Glucagon on Ischemic Heart Disease and Its Risk Factors: A Mendelian Randomization Study.Semantic proximity Read ↗

Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signallingSemantic proximity Read ↗

Genetic Variability of the Glucose-Dependent Insulinotropic Peptide Gene Is Involved in the Premature Coronary Artery Disease in a Chinese Population with Type 2 Diabetes.Semantic proximity Read ↗

Insulin Response to Oral Glucose and Cardiometabolic Disease: A Mendelian Randomization Study to Assess Potential Causality.Semantic proximity Read ↗

Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the GIPR Region.Semantic proximity Read ↗

Multiomics Insight Into the Role of Glucagon-Like Peptide-1 Receptor Agonists in Heart FailureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.